Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer

Autor: D W, Denham, M G, Franz, W, Denham, E E, Zervos, W R, Gower, A S, Rosemurgy, J, Norman
Rok vydání: 1998
Předmět:
Zdroj: Surgery. 124(2)
ISSN: 0039-6060
Popis: The level of expression of the alpha isoform of protein kinase C (PKC-alpha) has been shown to correlate inversely with the pathologic differentiation of human pancreatic cancers.We stably transfected a moderately differentiated pancreatic cell line (HPAC) to overexpress PKC-alpha and examined the survival rates compared with parent HPAC according to an orthotopic model. Next we used a PKC-alpha antisense oligonucleotide specifically to down-regulate this isoform in vitro and examine the effect of treatment in vivo again according to the orthotopic model.Animals implanted with the overexpressing cell line had a mortality rate almost twice that of those implanted with the parent cell line (P.01). Treatment with antisense oligonucleotide in increasing concentrations down-regulated PKC-alpha mRNA by Northern blot analysis and reverse transcriptase-polymerase chain reaction. Animals treated with antisense oligonucleotide after orthotopic implantation of pancreatic cancer cells survived statistically longer than those treated with vehicle alone (P = .005). Treatment with a scrambled oligonucleotide also conferred a survival benefit compared with vehicle alone (P.01).Tumorigenicity of pancreatic cancer is related directly to PKC-alpha expression in vivo as demonstrated by decreased survival when overexpressed. PKC-alpha expression can be down-regulated directly (antisense) and indirectly (scrambled) in vitro, which subsequently confers a dramatic survival benefit in vivo.
Databáze: OpenAIRE